Operator: Good afternoon, and welcome to Lumos Pharma s Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Lumos Pharma, Inc : Lumos Pharma Announces Departure of Chief Medical Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
AUSTIN, Texas, June 28, 2023 (GLOBE NEWSWIRE) Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone Deficiency (iPGHD) through Phase 2 clinical trials, announced .
Lumos Pharma Announces Departure of Chief Medical Officer itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.